Aug 10, 2022 / 08:30PM GMT
Operator
Good day, and welcome to the Capricor Therapeutics second-quarter 2022 earnings call. Today's conference is being recorded. At this time, I'd like to turn the conference over to AJ Bergmann, CFO. Please go ahead, sir.
AJ Bergmann - Capricor Therapeutics, Inc. - CFO
Thank you and good afternoon. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy, safety, and intended utilization of our product candidates; our future R&D plans, including our anticipated conduct and timing of preclinical and clinical studies; our plans to present or report additional data; our plans regarding regulatory filings; potential regulatory developments involving our product candidates; central milestone payments; and our possible uses of existing cash and investment resources.
These forward-looking statements are based on current information, assumptions, and expectations that are subject to change and involve a number
Q2 2022 Capricor Therapeutics Inc Earnings Call Transcript
Aug 11, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers